MONDAY, MARCH 27, 2017

Immune responses may inhibit antibody-based treatments for HIV

Researchers from the Medical University of South Carolina recently conducted studies to determine whether immune responses inhibit the results of broadly neutralizing antibody treatments that may help people with HIV infections. Read More »

Hong Kong health officials issue dengue fever update

Officials from Hong Kong's Centre for Health Protection (CHP), a branch of the Department of Health, recently published an update with the most recent number of dengue fever cases. Read More »

Brazil approves Sanofi Pasteur's dengue vaccine

Sanofi Pasteur, Sanofi’s vaccines division, recently received regulatory approval from Brazil for the company’s dengue fever vaccine, called Dengaxia, which is designed to protect people from contracting dengue fever from infected mosquitoes. Read More »

WHO to evaluate Merck's Ebola vaccine candidate

The World Health Organization (WHO) intends to evaluate the Emergency Use Assessment and Listing (EUAL) application for an investigational Ebola vaccine that has been developed by Merck. Read More »

Novel model of SIR-Network predicts dengue epidemics

A new model of SIR-Networks, shown in an article titled “SIR-Network Model And Its Application To Dengue Fever,” shows that there will soon be dengue fever epidemics based within urban regions. Read More »

Study reveals Ebola, bats wage molecular war

A recent study from the University of Colorado-Boulder, Albert Einstein College of Medicine, and the U.S. Army Medical Research Institute of Infectious Diseases has demonstrated that the Ebola virus and bats have fought a molecular war for centuries Read More »

Malaria uses inflammatory response to evade immune system

Australian scientists recently discovered that malaria parasites trigger an inflammatory response that prevents the immune system from protecting itself from malaria and its spread throughout the body. Read More »

WHO reports Guinea has halted Ebola transmission

The World Health Organization (WHO) recently stated that the Guinea has ended its Ebola transmission, as the last person who had the virus showed negative test results 42 days ago. Read More »

Leaders strive to improve malaria elimination strategy in India

Both local and international leaders are working on improvements that will help India's strategy for malaria elimination. Read More »

Officials in Congo report 474 deaths from measles

Congo's Ministry of Public Health recently released an update about the measles epidemic that has been taking place since the start of 2015. Read More »

Scripps team discovers possible treatment for deadly viruses

The Scripps Research Institute (TSRI) Florida campus researchers have discovered a potential treatment that could protect people from serious viruses like West Nile, dengue and Ebola. Read More »

Hong Kong officials confirm human Avian influenza case

Health professionals at Hong Kong's Centre for Health Protection (CHP) recently received confirmation that health care workers have detected Avian influenza A (H5N6) in a human. Read More »

Scientists find genetic risk of hyperinflammatory disorder among H1N1 patients

Researchers recently discovered a genetic risk that makes people who contract H1N1 flu more likely to develop a hyperinflammatory disorder that can cause death. Read More »

Nurse writes of experience fighting Ebola outbreak in West Africa

Registered Nurse Deborah Wilson recently published her experience of fighting the Ebola virus outbreak in West Africa to make the outbreak more human and approachable to the public. Read More »

CDC study shows extended regimens aid patients with MDR-TB

Regimens that involve a wider variety of drugs may help to improve the ultimate outcomes for patients when they have multi-drug resistant tuberculosis (MDR-TB). Read More »

Valenva sees global potential for cholera vaccine

Valenva SE, a pure-play vaccine company, recently released an update about the DUKORAL vaccine that it acquired from Crucell Holland BV. Read More »

Spanish researchers investigate HIV immunosuppression

Researchers from the Biomedical Research Institute have found that the adaptation of people who have severely immunosuppressed HIV infections largely relies on the host’s virologic and immunologic response to the virus itself. Read More »